Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma

JCO Oncology Practice(2024)10.1200/op.24.00089Source: DataRank Database

Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma is a research paper published in JCO Oncology Practice (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

refsnp nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.28)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Susan K. Parsons ORCID,Frank G. Keller ORCID,Lindsay A. Renfro ORCID,Qinglin Pei ORCID,Angie Mae Rodday ORCID

Live enrichment

PubMed:39303168 PMC:PMC11922787 OpenAlex:https://openalex.org/W4402670104

NCI NIH HHS

Grant: U10 CA098543

NCI NIH HHS

Grant: U10 CA180886

NCI NIH HHS

Grant: U10 CA180899

NCI NIH HHS

Grant: R50 CA285492

NCI NIH HHS

Grant: U10 CA029511

NCI NIH HHS

Grant: UG1 CA189955

FWCI

1.28

Citation Percentile

0.8%

Citation Trend

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11922787/

publisherhttps://ascopubs.org/doi/pdfdirect/10.1200/OP.24.00089

journalhttps://doi.org/10.1200/op.24.00089

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39303168

Fields of Study

Cancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchLymphoma Diagnosis and TreatmentHumansHodgkin DiseaseAdolescentChildYoung AdultPeripheral Nervous System DiseasesAntineoplastic Combined Chemotherapy ProtocolsFemaleMaleChild, PreschoolDoxorubicinCyclophosphamideAdultVincristine

MeSH Terms

AdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsChildChild, PreschoolCyclophosphamideDoxorubicinFemaleHodgkin DiseaseHumansMalePeripheral Nervous System DiseasesVincristineYoung Adult

Keywords

MedicineVincristineEtoposideCyclophosphamideOncologyInternal medicineChemotherapy-induced peripheral neuropathyPrednisonePeripheral neuropathyChemotherapyVincaPharmacology

Sustainable Development Goals

SDG 0: Good health and well-being